Christopher Morabito insider trades

Open-market stock purchases and sales by Christopher Morabito, Chief Medical Officer at Astria Therapeutics, Inc, from SEC Form 4 filings since May 10, 2021.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -60%.

Recent trades

DateStockTradeValue
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$310K
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$1.7M

Companies traded

  • ATXS Astria Therapeutics, Inc: 3 sales, last Jan 23, 2026
  • FULC Fulcrum Therapeutics, Inc: 1 buy, last Jan 19, 2022

Get free alerts when Christopher Morabito files a new trade →